| Auteur | |
|---|---|
| jiraporn66 | 23 Jun 2022 - 06:47:37 |
| 470 Posts |
 Pfizer Inc., the US pharmaceuticalSLOTXOgiant said. has applied for approval for the use of the COVID-19 vaccine Booster needles in children 5-11 years old told the Japanese Ministry of Health today. Kyodo News Agency reported that Although the 3rd dose vaccination is now widely available to adults in Japan. But children in that age group are still allowed to receive only 2 doses of the vaccine. Pfizer clinical trial data released in April showed that Booster vaccination increases the amount of antibodies that can inhibit the virus by 6 times when used in children 5-11 years of age approximately 6 months after the second dose of vaccine. Pfizer stated that The vaccine is effective against omikron strains and safety issues have not been identified. The U.S. Food and Drug Administration (FDA) approved the use of Pfizer's booster vaccine in children ages 5-11 in the United States in May.  |
  |
|
